Building a relationship for success

A tradition of innovation

Established in 1990, we began with the simple goal of providing clear, precise and timely solutions for the data needs of clinical trial professionals. Today, Symbiance continues to apply this tradition of precision, clarity and performance to its expanded portfolio of services. This includes a clinical data management unit, biostatistical analysis and SAS programming divisions.

Shawki Salem, Ph.D. in Biostatistics, founded Symbiance (formerly Princeton Biostatistics Group (PBG)) in 1990, after spending seventeen years in the pharmaceutical industry as a statistician, senior statistician, director and Senior Director of Biostatistics. Today, Symbiance has a twenty-plus year track record of success with clients such as Progenics, Wyeth, Eisai, Novartis and Pfizer.

Our achievements, past and current, are based in large part on the importance we place on nurturing the unique talents of our professional staff and the relationship we build with our customers. Symbiance, as our name suggests, stands for mutually beneficial interactions and successful collaborations. It’s what we strive for — to build a relationship for success.

Symbiance’s values

• Provide clients with quality service
• Hire and maintain reliable professionals
• Establish and maintain open communication with our clients

Trusted CRO partner for pharmaceutical and biotechnology companies

For over 20 years Symbiance has been at the cornerstone of the growth of the pharmaceutical and biotechnology industry. As a trusted partner to global pharma leaders, Symbiance is a renowned niche provider of clinical data management, biostatistics and medical writing services. With a commitment to quality assurance, successful collaboration through communication and dedication to our clients, Symbiance builds relationships for success.